Metabolism 5.2 Oxidative Stress and Antioxidant Defence Mechanisms
Oxidative Stress
Definition: Condition where generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) exceeds the body’s ability to protect itself.
Consequences include increased oxidative damage to macromolecules (proteins, lipids, DNA) leading to cell/tissue damage.
Imbalance between oxidants and antioxidants drives cellular injury and disease.
Redox Reactions (Foundational Concept)
Redox reactions: Involve simultaneous oxidation and reduction.
OIL RIG: Oxidation Is Loss, Reduction Is Gain of electrons.
Oxidizing agent (oxidant): Oxidises another substance and becomes reduced.
Reducing agent (reductant): Reduces another substance and is oxidised.
Practical implication: In biology, redox couples regulate signaling and oxidative damage.
Reactive Oxygen and Nitrogen Species (ROS & RNS)
Reactive Oxygen Species (ROS): Includes superoxide ( ext{O}2^{ullet-}), hydrogen peroxide (), hydroxyl radical ( ext{OH}^{ullet}).
Reactive Nitrogen Species (RNS): Includes nitric oxide ( ext{NO}^{ullet}) and peroxynitrite ().
Free radical definition: Atom/molecule with one or more unpaired electrons; highly reactive ( ext{OH}^{ullet}).
Readily diffusible and react with many cellular targets.
Key interaction: Superoxide reacts with nitric oxide to form peroxynitrite (), a powerful oxidant.
Formation of ROS in Cells
Electron Transport Chain (ETC) as a source: Electrons occasionally escape, reducing to form superoxide ( ext{O}2^{ullet-}).
Superoxide-derived ROS give rise to other ROS.
Other endogenous sources: Peroxidases, nitric oxide synthases, NADPH oxidases, xanthine oxidase.
Exogenous sources: Radiation, pollutants, drugs (e.g., paracetamol), toxins.
Key ROS/RNS Reactions and Consequences
Superoxide to hydrogen peroxide: Superoxide dismutase (SOD) converts ext{O}2^{ullet-} to .
Reaction:
Hydroxyl radical formation (Fenton chemistry): .
Peroxynitrite formation: .
Nitric oxide synthases (NOS): Generate ext{NO}^{ullet} from arginine (iNOS, eNOS, nNOS).
Nitric Oxide Synthase (NOS) and Nitric Oxide (NO)
NOS catalysis: Oxidation of arginine to citrulline and ext{NO}^{ullet}.
NOS cofactors: FMN, FAD, heme, tetrahydrobiopterin (BH4).
NO interactions: Reacts readily with , metals, nucleic acids, and proteins.
Low NO levels: Can inhibit cytochrome oxidase and support cell survival.
High NO levels: Damage mitochondrial complexes, cause post-translational modifications (nitrosylation), and lead to cell death.
Roles of NOS isoforms:
iNOS: Inducible, high ext{NO}^{ullet} production in phagocytes for antimicrobial effects.
eNOS: Endothelial signaling; vasodilation.
nNOS: Neuronal signaling.
DNA Damage from ROS
Two main ROS-induced DNA damages:
Base damage: Leading to mispairing and mutations (oxidized bases).
Sugar/phosphodiester damage: Causing strand breaks during repair.
8-Oxo-2′-deoxyguanosine (8-oxo-dG): Marker for oxidative DNA damage.
Accumulation correlates with cancer risk when repair is compromised.
Used as an oxidative damage biomarker.
DNA Damage from ROS (Overview of Consequences)
Consequences: ROS interactions with DNA drive mutations and genomic instability.
Failure to repair ROS-induced DNA lesions increases cancer risk.
Protein Damage from ROS
ROS attack on proteins leads to:
Backbone fragmentation.
Side-chain modifications: carbonylation, hydroxylation.
Formation of protein cross-links (e.g., di-tyrosine dimers).
Loss or gain of function due to structural changes (e.g., disulfide bonds in insulin).
Lipid Peroxidation and Membrane Damage
Mechanism: Unsaturated lipids react with ROS to form lipid peroxides.
Consequences: Damages cell membranes, alters fluidity, and generates reactive aldehydes.
Implicated in early cardiovascular disease processes.
Nitric Oxide Synthase (NOS)–NO in Cells (Detailed)
NOS reaction: .
NO interactions: Broaden signaling, but high NO can damage mitochondria and proteins.
Can participate in nitrosylation of thiol groups and other post-translational modifications.
Cellular Defence Mechanisms Against ROS/RNS
Major defenses: Enzymatic and non-enzymatic systems to maintain non-damaging ROS/RNS levels.
Non-enzymatic pool: Glutathione (GSH) in reduced (GSH) and oxidized (GSSG) forms.
Key enzymes:
Glutathione peroxidase (GPx): Reduces and organic peroxides using GSH.
Glutathione reductase (GR): Regenerates GSH from GSSG using NADPH.
NADPH oxidase (NOX): Generates ROS for signaling/defense; tightly regulated.
Nicotinamide adenine dinucleotide phosphate (NADPH): Reducing power for GSSG-to-GSH regeneration.
Pentose phosphate pathway (PPP): Generates NADPH, vital for maintaining GSH:GSSG ratio.
GSH regeneration cycle: .
GSH donates electrons (via cysteine thiol) to reduce oxidants, becoming GSSG.
GR regenerates GSH from GSSG using NADPH.
Maintains cellular redox homeostasis and detoxifies peroxides.
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
Definition: X-linked recessive enzyme deficiency, affects RBC protection against oxidative stress.
Common in African, Mediterranean, and Middle Eastern populations (400 million people).
Provides some protection against malaria.
Clinical presentation:
Most individuals asymptomatic.
Occasional severe haemolytic anaemia during oxidative stress (haemolytic crisis).
Pathophysiology:
G6PD deficiency lowers PPP NADPH production.
Reduced NADPH limits regeneration of GSH from GSSG.
Decreased GSH leads to vulnerability to ROS, causing damage.
Red cell consequences in oxidative crises: Heinz bodies, haemolysis.
G6PD Deficiency – Mechanistic View
Pathway disruption: G6PDH NADPH GSH reduction.
Consequences:
Oxidative stress–related damage to lipids, proteins, and DNA.
Heinz bodies formation and hemolytic anemia if exposed to oxidants.
Higher sensitivity to infection, certain drugs, and fava beans as triggers.
Heinz Bodies and Related RBC Pathology (Context of G6PD)
Heinz bodies: Dark inclusions due to precipitated hemoglobin (Hb) inside RBCs.
Bind to cell membrane, increasing rigidity and causing mechanical stress.
Spleen removes Heinz bodies, leading to blister cells.
Clinical sign of G6PD deficiency-related hemolysis.
Galactosaemia and Related Pathways (Oxygen/NADPH Context)
Galactosaemia: Defects in galactose metabolism enzymes (Galactokinase, Uridyltransferase, UDP-galactose epimerase).
Consequence: Accumulation of galactitol via aldose reductase (polyol pathway) consuming NADPH.
NADPH depletion: Compromises antioxidant defenses, contributing to cataracts, hepatic, and renal complications.
Metabolic flow: Dietary lactose galactose + glucose; galactose involved in polyol pathway.
Oxygen Toxicity (Clinical Implications of Excess Oxygen)
Mechanism: Excessive oxygen exposure increases ROS formation.
Detrimental effects: Damage to bronchioles/alveoli, retina, and other tissues.
Occurs in both infants and adults under prolonged respiratory support.
Diseases and Conditions Linked to Free Radical Damage (Broad Overview)
Multifactorial associations: ROS/RNS contribute but are not sole causes.
Linked conditions include:
Atheroma (atherosclerosis).
Cancers.
Autoimmune and inflammatory diseases (e.g., rheumatoid arthritis).
Neurodegenerative diseases (including dementia).
Cataracts and macular degeneration.
Aging processes.
Progression of Atheroma (Conceptual Model)
Progression: Healthy artery atheroma plaque formation plaque rupture thrombosis impaired blood flow.
Oxidative stress contributes to lipid oxidation and plaque instability.
Cellular Defences – Antioxidants (Non-enzymatic Defenders)
Vitamin E (-tocopherol): Lipid-soluble antioxidant; protects against lipid peroxidation.
Vitamin C (ascorbic acid): Water-soluble antioxidant; regenerates reduced Vitamin E.
Vitamin E scavenges lipids and becomes oxidized; Vitamin C regenerates reduced Vitamin E.
Other non-enzymatic antioxidants: Carotenoids, flavonoids, selenium (cofactor for GPx), uric acid, melatonin, zinc.
General mechanism: Free radical scavengers donate a hydrogen atom (and its electron) to neutralize free radicals.
Antioxidant Enzyme Systems (Key Players)
SOD: Converts superoxide to hydrogen peroxide.
CAT (catalase) and GPX (glutathione peroxidase): Convert hydrogen peroxide to water.
GSR (glutathione reductase): Regenerates GSH from GSSG using NADPH.
GST (glutathione-S-transferase): Involved in detoxification pathways.
Metal cofactors: Mn, Cu, Zn.
Antioxidant Foods and Supplements – Practical Perspective
Dietary antioxidants: Vitamins A, C, E; minerals Mn, Se, Zn; carotenoids; plant-based foods (fruits, vegetables, coffee, dark chocolate).
Caveat: Not miracle cures; claims should be interpreted cautiously.
Supplements: Can be helpful but not a panacea; effectiveness varies.
Respiratory Burst (Phagocytic Defense) and CGD
Respiratory Burst: Phagocytes (e.g., neutrophils) rapidly release ROS/ to destroy invading bacteria.
Chronic Granulomatous Disease (CGD): Genetic defects in the NADPH oxidase complex.
Leads to increased susceptibility to infections (atypical infections, pneumonia, abscesses, cellulitis).
Respiratory burst is a controlled ROS burst for immunity; defects heighten infection risk.
Summary of Key Concepts (Cohesive View)
Oxidative stress: ROS/RNS production exceeding defenses, causing damage to DNA, proteins, lipids.
ROS/RNS formation: Mitochondrial leakage, NO synthases, NADPH oxidases, other sources.
ROS damages: DNA base/sugar damage (e.g., 8-oxo-dG), protein oxidation, lipid peroxidation, contributing to various diseases.
Antioxidant defenses: Enzymatic systems (SOD, CAT, GPX, GR, GST) and non-enzymatic antioxidants (Vitamins E/C, carotenoids, GSH/GSSG cycle, NADPH via PPP).
NADPH central role: Regenerating reduced antioxidants (GSH) and enzymatic defenses; PPP is primary source.
G6PD deficiency: Limits NADPH supply, compromising oxidative defense, leading to hemolysis and Heinz bodies.
NOS/NO biology: Dual roles ranging from physiological signaling to cytotoxicity at high levels or with ONOO.
Oxygen toxicity: Excessive ROS from prolonged high oxygen exposure clinically.
Pathophysiological links: Atheroma progression, cancer, neurodegeneration.
Clinical implications: Cautious use of oxidant drugs, awareness of G6PD status (e.g., with nitrofurantoin, primaquine), judicious oxygen therapy.
Notable Ancillary Content (contextual and non-core items from the transcript)
Product advertisement: Mothballs, medication panel (Page 23).
Educational inserts: Oxygen toxicity in clinical care (Page 26–27).
Galactosaemia section: Metabolic pathway details and NADPH consumption via aldose reductase (Page 23–25).
Summary citation list: References to antioxidant studies (Page 35).
Connections to Foundational Principles and Real-World Relevance
Redox biology: Unifying framework for understanding aging, cancer, neurodegeneration, cardiovascular disease.
Balance: Between ROS production and antioxidant capacity is a dynamic determinant of cell fate.
Real-world relevance: Clinical strategies (CGD diagnosis/management, NADPH-dependent antioxidant support, oxygen therapy) and public health (dietary antioxidants, malaria resistance in G6PD deficiency).
Equations and Key Reactions (LaTeX)
Superoxide formation: .
Dismutation of superoxide by SOD:
Fenton reaction: .
Peroxynitrite formation: .
NOS-catalyzed NO production: .
GSSG reduction by NADPH: .
GPx-catalyzed reduction of : .
PPP-derived NADPH support: Conceptual role in sustaining GSH/GSSG balance.
Key Takeaways for Exam Preparation
Define oxidative stress: Explain ROS/RNS balance and cellular outcomes.
List major ROS/RNS: Their interconversions (, , , , , ).
Describe ETC as ROS source: How ROS are formed inadvertently.
Enumerate oxidant sources: Endogenous and exogenous.
Explain ROS damage: DNA (8-oxo-dG), proteins (carbonylation), lipids (lipid peroxidation).
Outline NOS/NO biology: iNOS/eNOS/nNOS roles and dual nature of NO.
Describe GSH/GSSG cycle: Role of GPx, GR, and importance of NADPH/PPP.
Explain G6PD deficiency: Inheritance, relevance, clinical consequences, Heinz bodies.
Recognize oxygen toxicity: Clinical implications of oxygen therapy.
Recall respiratory burst and CGD: Model of defense and infection vulnerability.
Understand broad connections: Oxidative stress and diseases (atheroma, cancer, neurodegeneration, aging).